Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
General Research Article

Use of Saliva to Assess the Adherence to Treatment with Oral Hypoglycemic Agents in Patients with Type 2 Diabetes

Author(s): Heloisa de Faria Baltazar, Fernando Luiz Affonso Fonseca, Paula Midori Castelo, Beatriz da Costa Aguiar Alves, Thaís Gascón, Glaucia Luciano da Veiga* and Edimar Cristiano Pereira

Volume 23, Issue 8, 2023

Published on: 20 March, 2023

Page: [1068 - 1076] Pages: 9

DOI: 10.2174/1871530323666230110123143

Price: $65

Abstract

Background: The diagnosis of Type 2 Diabetes Mellitus (T2DM) is made by demonstrating the hypoglycemic condition, which involves the determination of plasma glucose, and the follow-up of hypoglycemic treatment is performed by assessing the glycated hemoglobin (HbA1c) concentration.

Aim: The aim of this study was to evaluate the saliva as an alternative sample in assessing the adherence to treatment with oral hypoglycemic agents in patients with Type 2 Diabetes.

Methods: We selected 68 patients with T2DM, who were subjected to venous blood and saliva collection, in addition to answering a standardized questionnaire on adherence to hypoglycemic treatment. Laboratory tests performed on saliva, whole blood, serum or plasma included assessment of glycemia, urea, creatinine, uric acid, total cholesterol, HDL-cholesterol, LDL-cholesterol, VLDL-cholesterol, and glycated hemoglobin.

Results: It was concluded that 82% of the patients adhered to hypoglycemic treatment based on glycated hemoglobin concentration (cut-off value of 7.0%). Comparing the groups that adhered to hypoglycemic treatment and those that did not adhere, statistical differences (P<0.05) were observed in the glucose, HDL-cholesterol, triglycerides, and insulin use (insulin therapy) parameters. Plasma glucose and urea serum concentration showed positive correlations when compared to saliva samples. Regarding the questionnaire, it was found that 35% of the patients presented positive screening for belief barriers and 83% positive score for recall barriers, and the positive screening correlated with glycated hemoglobin.

Conclusion: Data have shown that it is possible to use saliva as an alternative sample to the laboratory assessment of hypoglycemic treatment adherence in T2DM patients.

« Previous Next »
Graphical Abstract

[1]
Association, A.D. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2019. Diabetes Care, 2019, 42(Suppl. 1), S13-S28.
[http://dx.doi.org/10.2337/dc19-S002] [PMID: 30559228]
[2]
Kreutzkamp, B. Drug treatment of diabetes mellitus type 2. Med. Monatsschr. Pharm., 2016, 39(2), 58-62.
[PMID: 26983333]
[3]
Bozkurt, B.; Aguilar, D.; Deswal, A.; Dunbar, S.B.; Francis, G.S.; Horwich, T.; Jessup, M.; Kosiborod, M.; Pritchett, A.M.; Ramasubbu, K.; Rosendorff, C.; Yancy, C. Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the american heart association. Circulation, 2016, 134(23), e535-e578.
[http://dx.doi.org/10.1161/CIR.0000000000000450] [PMID: 27799274]
[4]
Saxton, S.N.; Clark, B.J.; Withers, S.B.; Eringa, E.C.; Heagerty, A.M. Mechanistic links between obesity, diabetes, and blood pressure: role of perivascular adipose tissue. Physiol. Rev., 2019, 99(4), 1701-1763.
[http://dx.doi.org/10.1152/physrev.00034.2018] [PMID: 31339053]
[5]
Roden, M. Diabetes mellitus: definition, classification and diagnosis. Wien. Klin. Wochenschr., 2016, 128(S2), 37-40.
[http://dx.doi.org/10.1007/s00508-015-0931-3] [PMID: 27052219]
[6]
Pfeiffer, A.F.; Klein, H.H. The treatment of type 2 diabetes. Dtsch. Arztebl. Int., 2014, 111(5), 69-81.
[PMID: 24612534]
[7]
Naing, C.; Mak, J.W. Salivary glucose in monitoring glycaemia in patients with type 1 diabetes mellitus: a systematic review. J. Diabetes Metab. Disord., 2017, 16(1), 2.
[http://dx.doi.org/10.1186/s40200-017-0287-5] [PMID: 28127542]
[8]
De Cock, L.; Hutse, V.; Verhaegen, E.; Quoilin, S.; Vandenberghe, H.; Vranckx, R. Detection of HCV antibodies in oral fluid. J. Virol. Methods, 2004, 122(2), 179-183.
[http://dx.doi.org/10.1016/j.jviromet.2004.09.001] [PMID: 15542142]
[9]
Javaid, M.A.; Ahmed, A.S.; Durand, R.; Tran, S.D. Saliva as a diagnostic tool for oral and systemic diseases. J. Oral Biol. Craniofac. Res., 2016, 6(1), 67-76.
[http://dx.doi.org/10.1016/j.jobcr.2015.08.006] [PMID: 26937373]
[10]
Simpson, S.H.; MacCallum, L.; Mansell, K. Pharmacy practice and diabetes care. Can. J. Diabetes, 2017, 41(6), 549-550.
[http://dx.doi.org/10.1016/j.jcjd.2017.09.005] [PMID: 29224632]
[11]
Ben, A.J.; Neumann, C.R.; Mengue, S.S. The Brief Medication Questionnaire and Morisky-Green test to evaluate medication adherence. Rev. Saude Publica, 2012, 46(2), 279-289.
[http://dx.doi.org/10.1590/S0034-89102012005000013] [PMID: 22331180]
[12]
Chiappin, S.; Antonelli, G.; Gatti, R.; De Palo, E.F. Saliva specimen: A new laboratory tool for diagnostic and basic investigation. Clin. Chim. Acta, 2007, 383(1-2), 30-40.
[http://dx.doi.org/10.1016/j.cca.2007.04.011] [PMID: 17512510]
[13]
Desai, G.S.; Mathews, S.T. Saliva as a non-invasive diagnostic tool for inflammation and insulin-resistance. World J. Diabetes, 2014, 5(6), 730-738.
[http://dx.doi.org/10.4239/wjd.v5.i6.730] [PMID: 25512775]
[14]
Mrag, M.; Kassab, A.; Omezzine, A.; Belkacem, C.R.; Ben, F.I.F.; Douki, N.; Laouani, K.C.; Bouslema, A.; Ben, A.F. Saliva diagnostic utility in patients with type 2 diabetes: Future standard method. J. Med. Biochem., 2020, 39(2), 140-148.
[PMID: 33033445]
[15]
Satish, B.N.; Srikala, P.; Maharudrappa, B.; Awanti, S.M.; Kumar, P.; Hugar, D. Saliva: A tool in assessing glucose levels in diabetes mellitus. J. Int. Oral Health, 2014, 6(2), 114-117.
[PMID: 24876711]
[16]
Dhanya, M.; Hegde, S. Salivary glucose as a diagnostic tool in Type II diabetes mellitus: A case-control study. Niger. J. Clin. Pract., 2016, 19(4), 486-490.
[http://dx.doi.org/10.4103/1119-3077.183314] [PMID: 27251965]
[17]
Caixeta, D.C.; Aguiar, E.M.G.; Cardoso-Sousa, L.; Coelho, L.M.D.; Oliveira, S.W.; Espindola, F.S.; Raniero, L.; Crosara, K.T.B.; Baker, M.J.; Siqueira, W.L.; Sabino-Silva, R. Salivary molecular spectroscopy: A sustainable, rapid and non-invasive monitoring tool for diabetes mellitus during insulin treatment. PLoS One, 2020, 15(3)e0223461
[http://dx.doi.org/10.1371/journal.pone.0223461] [PMID: 32182246]
[18]
Gonzalez, J.S.; Tanenbaum, M.L.; Commissariat, P.V. Psychosocial factors in medication adherence and diabetes self-management: Implications for research and practice. Am. Psychol., 2016, 71(7), 539-551.
[http://dx.doi.org/10.1037/a0040388] [PMID: 27690483]
[19]
Donnelly, L.A.; Morris, A.D.; Evans, J.M.M. Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. QJM, 2007, 100(6), 345-350.
[http://dx.doi.org/10.1093/qjmed/hcm031] [PMID: 17504861]
[20]
Schectman, J.M.; Nadkarni, M.M.; Voss, J.D. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care, 2002, 25(6), 1015-1021.
[http://dx.doi.org/10.2337/diacare.25.6.1015] [PMID: 12032108]
[21]
Stolar, M. Glycemic control and complications in type 2 diabetes mellitus. Am. J. Med., 2010, 123(3), S3-S11.
[http://dx.doi.org/10.1016/j.amjmed.2009.12.004] [PMID: 20206730]
[22]
Lima-Aragão, M.V.V.; de Oliveira-Junior, J.J.; Maciel, M.C.G.; Silva, L.A.; do Nascimento, F.R.F.; Guerra, R.N.M. Salivary profile in diabetic patients: biochemical and immunological evaluation. BMC Res. Notes, 2016, 9(1), 103.
[http://dx.doi.org/10.1186/s13104-016-1881-1] [PMID: 26879274]
[23]
Fares, S.; Said, M.S.M.; Ibrahim, W.; Amin, T.T.; Saad, N.E.S. Accuracy of salivary glucose assessment in diagnosis of diabetes and prediabestes. Diabetes Metab. Syndr., 2019, 13(2), 1543-1547.
[http://dx.doi.org/10.1016/j.dsx.2019.03.010] [PMID: 31336519]
[24]
Khoury, Z.H.; Illesca, P.; Sultan, A.S. Salivary fructosamine as a noninvasive glycemic biomarker: a systematic review. JDR Clin. Trans. Res., 2021, 6(4), 382-389.
[http://dx.doi.org/10.1177/2380084420954354] [PMID: 32881595]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy